The US Oncology Network believes local cancer care is better care. We empower the delivery of advanced integrated cancer care through our network of independent physicians who share expertise and resources to provide quality, value-based care close to home.
In 2017, we were excited to welcome Vantage Oncology into The US Oncology Network. Vantage Oncology and its physician partners broaden The US Oncology Network’s expertise in radiation oncology and extend the footprint of The US Oncology Network.
In 2017, we were excited to welcome Vantage Oncology into The US Oncology Network. Vantage Oncology and its physician partners broaden The US Oncology Network’s expertise in radiation oncology and extend the footprint of The US Oncology Network.
Location: United States, Texas, Kyle
Employees: 1001-5000
Phone: +1 866-951-2774
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Baleon Cap... | baleoncapi... |
Mentions in press and media 12
| Date | Title | Description |
| 18.04.2025 | McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care | What You Should Know: – McKesson has unveiled the Precision Care Companion (PCC), a transformative initiative designed to tackle the multifaceted challenges that healthcare practices face in the rapidly evolving landscape of genomic testing... |
| 04.04.2025 | Daymark Health: A New Dawn in Cancer Care | In the world of cancer care, change is often slow. But Daymark Health is here to flip the script. This Philadelphia-based company has just raised $11.5 million in seed funding, a shot in the arm for its ambitious mission. Co-led by Maverick... |
| 03.04.2025 | Daymark Health Raises $11.5M in Seed Funding | Daymark Health, a Philadelphia, PA-based cancer care company, raised $11.5m in seed funding. The round was co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Ventures. The company intends to use the funds ... |
| 03.04.2025 | Daymark Health Launches with $11.5M to Redefine Cancer Care | What You Should Know: – Daymark Health, a company aiming to redefine the cancer care experience, has publicly launched with an $11.5M in seed funding co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Vent... |
| 25.01.2025 | Inside the IT Genius Transforming Healthcare Networks: Sunday Oladosu’s Innovations in Mobile Diagnostics and Data Security | Share Tweet Share Share Email In the evolving world of healthcare, robust and secure networks form the foundation of effective and innovative care support for a patient. Today it is a matter of life and death to provide accurate and secure ... |
| 12.12.2024 | Optimizing MIPS Value Pathways (MVPs) for Oncology Practices in 2025 | Erin Crum, Sr. Director of Quality Strategy and Innovation, The US Oncology Network and McKesson The Centers for Medicare and Medicaid Services (CMS) introduced the MIPS Value Pathways (MVPs) as part of its ongoing revisions to the Merit-Ba... |
| 02.04.2024 | Gilbane, Inc. Announces Appointment of William F. McKeon to Board of Directors | William F. McKeon, President & CEO of the Texas Medical Center, joins Gilbane, Inc.'s Board of Directors. (PRNewsfoto/Gilbane, Inc.) Healthcare chief executive brings global life sciences expertise to Gilbane, a leader in construction s... |
| 18.04.2023 | MatTek Life Sciences and NEXT Oncology Announce Licensing Agreement to Develop Lab-Grown Tumors | “Using the panel of cancer types, we will develop a drug screening protocol that can determine effective drugs for specific cancer types and be applied for personalized medicine,” said Dr. Anthony Tolcher, CEO and founder of NEXT Oncology. ... |
| 29.12.2022 | Greenwich LifeSciences Provides Year End Update | Greenwich LifeSciences, Inc. GLSI (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone ... |
| 09.12.2021 | US Oncology Research, The US Oncology Network and Ontada Announce Data Presentations Across Areas of Critical Need at 2021 American Society of Hematology Annual Meeting and Exposition | Investigators from US Oncology Research, The US Oncology Network (The Network), and OntadaTM will share results from more than 30 studies exploring areas such as diffuse large B cell lymphoma, non-Hodgkin lymphoma, multiple myeloma and hema... |
Show more